Product Review

DoNotAge Berberine Review: 500 mg Capsules, Evidence and Value

5/5 Editorial scoreRECOMMENDED

Our preferred straightforward berberine capsule. The current official page states 500 mg per capsule and a 98%-purity HCl ingredient, with HPMC capsules and no added fillers. The strongest human evidence...

500 mg berberine

Check price at DoNotAge Read our verdict

Save 10% with code

BB10: 10% off eligible standalone products. Routine, Performance and Yearly Supply have separate offers. Check the discount guide for terms. Offer terms and exclusions

Partner link. We may earn a commission at no extra cost to you.

Full affiliate disclosure

Biohack Blueprint is a DoNotAge affiliate and may earn commission from qualifying purchases through the tracked links on this page. The recommendation is an editorial preference, not a blinded market-wide test or proof of brand-specific clinical efficacy. Orders are placed with DoNotAge.

By Dr. Khaled Mahmoud, MBBCh

Reviewed by Dr. Amr Yasser, PhD, Dr. Abdulla Mostafa, PhD

· 13 min read

How we scored it

Our editorial recommendation uses a 1–5 scale. We consider the formulation, label clarity, manufacturer quality disclosures, practical use and value for the intended reader. The published rating is an overall editorial judgment; these factors are not separately measured or weighted.

5/5 means a top editorial recommendation for the stated use case. It does not establish clinical effectiveness or mean that we performed laboratory testing. Research strength and safety limitations are assessed separately in this review.

Subjective product-fit score for a clear conventional formula, practical capsule amount, simple ingredients, manufacturer documentation route and value. Not a clinical-efficacy or independent laboratory score.

Read the review summary

A straightforward conventional HCl capsule, assessed through its current label, manufacturer information and relevant human research. Our preference is for product fit and value; efficacy depends on the endpoint and person.

Our preferred straightforward berberine capsule. The current official page states 500 mg per capsule and a 98%-purity HCl ingredient, with HPMC capsules and no added fillers. The strongest human evidence concerns selected glucose and lipid markers; weight and liver-fat findings are mixed, and human life extension is unproven. This 5/5 editorial recommendation concerns product fit, with our affiliate relationship disclosed.

Evidence for an ingredient does not establish the effects of this finished product. See the evidence section for study design, dose and limitations.

DoNotAge Pure Berberine bottle, 60 capsules View image

DoNotAge Pure Berberine bottle, 60 capsules

Read the full editorial assessment

This DoNotAge Berberine review evaluates our preferred straightforward conventional capsule: 500 mg per capsule, a simple HCl formulation and manufacturer-reported batch testing. It is an appealing product for a reader who has already decided, with appropriate clinical input, that berberine fits a measurable metabolic goal.

Our recommendation is about the product proposition. It is not a claim that the current retail bottle has been proven to produce every benefit in the wider literature. Biohack Blueprint is a DoNotAge affiliate and may earn commission from qualifying purchases.

Our editorial verdict

We rate the product 5/5 for a clear set of product-selection criteria: a straightforward conventional HCl option with clear unit dosing, a simple formula, accessible quality-documentation route and competitive starting-price context. This is a subjective product-fit recommendation, not a clinical-efficacy score, independent purity assay or blinded market-wide test.

The strongest reasons to choose it are practical. It is easy to understand what one capsule supplies, the form is closer to several important conventional-berberine trials than an unspecified blend, and the manufacturer offers product-specific information and a route to request certificates of analysis.

Current product facts

  • Ingredient: Berberine HCl
  • Capsule amount: 500 mg
  • Purity statement: 98%, according to the product quality section
  • Capsule shell: HPMC, described as plant-based
  • Added fillers: Manufacturer states none
  • Pack choices: 60 and 366 capsules
  • Displayed US starting price: From $24; options and regions differ
  • Testing: Manufacturer states in-house and third-party testing; CoAs on request

The source is the official product page. We have not independently laboratory-assayed the current retail lot. The current product page states 98% purity; specifications for other DoNotAge ingredients do not describe this product.

Why the formulation makes sense

Conventional berberine has been studied in human glucose and lipid research. A 116-participant placebo-controlled trial used 1 g/day, while other studies used different regimens. The ingredient has a meaningful research base, although its limitations should remain visible. [1] [2] [3]

A 500 mg capsule makes arithmetic straightforward, but capsule strength does not establish the right daily amount for a particular person. The official FAQ currently describes 500–1,000 mg/day as typical and advises taking it with a meal. Subscription quantities for larger intakes are supply options, not a clinical dosing endorsement.

Blood sugar: the most relevant positive evidence

Controlled studies support improvements in selected glucose-related markers in people with type 2 diabetes. PREMOTE reported a berberine-alone HbA1c change of about -0.99 percentage points versus -0.59 with placebo, a difference of roughly 0.40 percentage points. [3]

That is useful evidence for the ingredient and research regimen. It does not establish that this exact DoNotAge bottle was tested, that every buyer will respond or that a person should replace prescribed treatment.

A small prediabetes pilot using a different branded preparation was encouraging, but it did not establish long-term diabetes prevention. [4]

Cholesterol: promising marker findings

The lipid literature includes early mechanistic studies, randomized work and newer apoB-related research. These findings make an identified lipid goal a reasonable subject for clinical discussion. [5] [6] [7]

They do not establish the same clinical-event protection as every established lipid therapy. The product recommendation concerns the capsule's label and proposition; the strength of evidence differs by endpoint.

Weight and fatty liver: set the expectation correctly

The updated obesity synthesis estimated a small average weight difference of about 0.88 kg. BRAVO then found no significant benefit for its primary visceral-fat and liver-fat outcomes after six months of conventional berberine HCl. [8] [9]

These results do not make a well-specified capsule a poor product. They do mean it should be purchased for a realistic, relevant objective rather than a guaranteed transformation, selective belly-fat loss or a liver cleanse.

Earlier fatty-liver findings and combination research involve different designs and interventions. HTD1801, an investigational berberine ursodeoxycholate compound, is not the same as this HCl capsule. [10] [11]

Longevity and mechanism

Experimental work connects berberine with mitochondrial complex-I inhibition and AMPK-related signaling. Mouse and worm studies provide further scientific interest, but human lifespan extension is not established. [12] [13] [14]

A clean, practical formulation does not need an exaggerated life-extension claim to be worth considering. Product quality and evidence strength should be evaluated separately.

Testing and the certificate of analysis

DoNotAge states that its batches are tested in-house and by third parties and that certificates are available on request. That is a useful transparency route. Buyers should ask for documentation matching the actual product and lot, including identity, potency and relevant contaminant testing.

A historical assay of commercial berberine preparations found substantial potency variation. It explains why verification matters, but it does not rank today's DoNotAge lot or prove that every competing brand is inferior. [15]

Our assessment uses published information and source review, not a laboratory comparison performed by Biohack Blueprint. This distinction is part of the recommendation, not a reason to ignore the manufacturer's quality process.

Dose, tolerance and medicines

The dosage guide compares actual study amounts, while the timing guide explains the meal instructions. Do not increase intake simply because a research paper or subscription selector lists a larger amount.

Digestive effects are possible. Repeated berberine exposure affected CYP enzymes in a human study, and cyclosporine interaction research demonstrates why a medication review matters. [2] [16] [17]

Pregnancy and breastfeeding use is generally avoided; preconception questions need individual advice. Rare cardiac-rhythm reports warrant proportionate attention, particularly in susceptible people, without being treated as a measured population incidence. [18] [19] [20]

Who is it most suitable for?

The strongest fit is an adult seeking a clearly specified conventional capsule for an identified metabolic goal, after appropriate medicine and health review. It also suits a buyer who values a simple formula and wants a direct route to manufacturer documentation.

It is a poor fit for someone seeking a guaranteed weight-loss result, a replacement for necessary medicine, a proven fertility treatment or a validated human life-extension intervention. PCOS evidence and pregnancy safety need their own assessment. [21] [22]

How it compares

Thorne's dual-form product combines HCl with a Phytosome ingredient; NOW and Integrative Therapeutics offer conventional options with different pack and excipient details. These are product-design comparisons, not a head-to-head clinical ranking.

Enhanced absorption can be relevant, but the larger exposure in a small formulation study is not proof of proportionately greater metabolic benefit. A tiny DHB pilot found no significant acute glycemic advantage despite exposure differences. [23] [24]

Our best-berberine guide compares current official labels in detail. DoNotAge earns our first-place preference for a straightforward conventional formula, with the commercial relationship disclosed.

Buying, pack size and BB10

Use the purchase link on this page and apply BB10 for 10% off eligible purchases. Confirm the final price, pack size, shipping, subscription terms and exclusions at checkout. The link is an affiliate referral and purchases are completed with DoNotAge.

A 366-capsule pack contains 366 one-capsule days or 183 two-capsule days; that is supply arithmetic, not personalized dosing advice. A starting price is not the price of every pack, and a discount should not be assumed to stack with every offer.

Our recommendation

For the reader who wants a straightforward 500 mg HCl capsule, DoNotAge is our preferred overall product proposition. Its value comes from a clear formula, practical unit size, manufacturer-reported quality standards and an understandable purchasing route.

Choose it with a specific goal and realistic expectations. The Berberine Data Center and the related guides make the evidence available beyond the purchase decision, including findings that are positive, limited or null.

Formulation strengths and limitations

What stands out

  • Clear 500 mg conventional HCl capsule for straightforward label comparison.
  • Manufacturer states a simple HPMC capsule without added fillers.
  • In-house and third-party testing stated, with certificates available on request.
  • 60- and 366-capsule formats and a starting-price proposition that is easy to check.

Things to know first

  • This review does not independently laboratory-assay the current retail lot.
  • The cited trials do not establish this exact retail product as their intervention.
  • Medicine review and realistic expectations remain necessary for the ingredient.

Key takeaways

  • Our 5/5 score is an editorial product-fit recommendation, not a clinical-efficacy or independent laboratory score.
  • The current official page states 500 mg per capsule and a 98%-purity HCl ingredient.
  • DoNotAge’s current retail bottle is not established as the tested product in the cited metabolic trials.
  • BB10 offers 10% off eligible purchases; checkout terms and exclusions apply.
500 mg conventional HCl Vegan formula stated Batch testing stated CoAs available on request

Formulation

Key facts & composition

Capsule amount 500 mg berberine Current manufacturer statement; the HCl form is identified on the product page.
Form Conventional berberine HCl No proprietary absorption multiplier is needed to interpret the unit amount.
Purity statement 98% Manufacturer statement, not an assay performed by Biohack Blueprint.
Capsule and extras HPMC; no added fillers stated Current official FAQ; check the actual regional bottle.
Pack choices 60 or 366 capsules Supply depends on the intended daily intake.
US starting price From $24 Checked October 22, 2026; pack, region, shipping and terms can change.
Quality documentation CoAs available on request Request the report matching the finished product and current lot.
Reader code BB10 10% off eligible purchases; confirm exclusions and final checkout total.

Composition

Ingredient Amount Form Source
Berberine hydrochloride 500 mg per capsule Conventional HCl Berberis species, according to the manufacturer

The current product page describes a 98%-purity ingredient enclosed in an HPMC capsule without added fillers. The stated capsule amount is not a universal daily recommendation. Request the current lot documentation for the relevant specification and assay.

Who this is for

Good fit if you're...

A clearly specified conventional capsule

You value a simple 500 mg unit and a formulation that is easy to compare with conventional research.

A measurable metabolic objective

You have reviewed medicines and the intended glucose or lipid goal with a clinician.

A buyer who wants documentation

You are prepared to request the current-lot certificate and compare the actual checkout terms.

Probably not for you if...

A guaranteed weight-loss promise

The ingredient evidence does not support predictable transformations or selective belly-fat removal.

Replacing necessary treatment

This is not an interchangeable substitute for prescribed diabetes, lipid, fertility or other care.

Pregnancy or breastfeeding self-use

Reproductive safety is not established and specialist sources advise avoidance.

How it works

Berberine research spans mitochondrial energy signaling, intestinal microbial metabolism and lipid handling. These mechanisms explain why clinical trials are worth conducting, but the outcome data—not a pathway label—determine which health claims are justified. Conventional HCl, combination formulas, DHB and investigational compounds remain distinct.

1

Energy-sensing pathways

Experimental research links berberine to inhibition of mitochondrial respiratory complex I and changes in cellular energy signaling, including AMPK-related responses. That mechanism should not be simplified into a guarantee of more cellular energy or an exercise-equivalent effect. Dose, tissue and metabolic context matter. It provides a rationale for testing, while controlled human outcomes decide which clinical claims are justified.

2

Intestinal and microbial actions

PREMOTE connects a human glucose outcome with microbial and metabolite analyses in a defined diabetes protocol. Conventional berberine can have biological activity despite low measured systemic exposure. However, PREMOTE included antibiotic pretreatment and should not be presented as a universal gut-reset routine or an instruction to use antibiotics before supplementation.

3

Lipid handling

The lipid literature includes LDL-receptor-related mechanisms and human changes in LDL, apoB and other markers. The newer sex-specific report adds useful detail but partly reuses a prior male trial cohort. These biomarker findings are relevant to a metabolic discussion; they do not establish the same cardiovascular event reduction as every proven lipid therapy.

Research & evidence

24 cited sources · Berberine Data Center

The evidence

Sources include research papers and other cited records, such as registered trials. A trial registration is not a published result.

The grades below concern the strength of evidence for each health claim, separately from the 5/5 product-fit recommendation. A better-supported glucose or lipid signal does not imply large weight loss, reliable fertility improvement or longer human life. Study populations, comparators, preparation and primary versus secondary endpoints matter. The current DoNotAge retail bottle is not established as the intervention in these trials.

B Selected glucose-related markers Tier 2

Several controlled studies support glucose and HbA1c improvements in type 2 diabetes. In PREMOTE, the approximate active-versus-placebo contrast was 0.40 percentage points, not the entire 0.99-point active-arm fall. Populations, preparations and background care differ; this is not proof that the DoNotAge retail bottle was tested or that it can replace prescribed treatment.

Zhang Y et al. 2008 , Zhang Y et al. 2020 , Yin J et al. 2008

B LDL cholesterol and apoB Tier 2

Human trials support a lipid signal. The 2026 sex-specific report found larger selected responses in women, while BRAVO reported modest secondary LDL and apoB changes. These are marker outcomes with study-specific limitations, not a demonstrated universal reduction in heart attacks or an exact brand-versus-brand efficacy ranking.

Zhao JV et al. 2026 , Lei L et al. 2026 , Kong W et al. 2004

C Weight-management outcomes Tier 2

The updated synthesis estimated a small mean weight difference of about 0.88 kg. BRAVO did not significantly improve primary visceral-fat or liver-fat outcomes after six months. A quality capsule should therefore be evaluated with realistic expectations, without a guaranteed transformation or selective belly-fat promise.

Elahi Vahed I et al. 2026 , Lei L et al. 2026

C Fatty-liver outcomes Tier 2

Earlier open-label research was encouraging, but the newer BRAVO result was null for liver fat in diabetes-free adults with obesity and MASLD. Enzymes, fat and fibrosis are different endpoints. Results for HTD1801 or other combinations cannot automatically be transferred to this conventional HCl product.

Yan HM et al. 2015 , Lei L et al. 2026 , Ji L et al. 2025

D PCOS and fertility claims Tier 2

A 2026 integrity-based appraisal raised unresolved concerns about its eligible trials. A separate large fertility trial did not improve live births by adding berberine to letrozole. This evidence does not support a confident fertility promise or use during pregnancy; clinical goals and reproductive safety need individual assessment.

Perera E et al. 2026 , Wu XK et al. 2016

D Human lifespan extension Tier 4

Mouse and worm experiments provide mechanistic and model-specific lifespan signals. They do not establish extra human years, a validated anti-aging dose or a clinical outcome for the current retail capsule. The editorial recommendation is about product fit, not proof of life extension.

Dang Y et al. 2020 , Bei Y et al. 2025 , Turner N et al. 2008

Label and manufacturer information checked October 22, 2026. Biohack Blueprint has not independently laboratory-assayed the current retail lot; the cited studies do not establish this bottle as their intervention.

Comparison

How it compares

DoNotAge Berberine Review: 500 mg Capsules, Evidence and ValueThorne Berberine NOW Berberine HCl 500 mg
Formulation Conventional berberine HCl HCl plus Phytosome Conventional berberine HCl
Amount clarity 500 mg per capsule 450 mg HCl + 550 mg complex per 2 capsules 500 mg per capsule
Additional formulation ingredients HPMC shell; no added fillers stated HPMC shell and calcium laurate listed Several excipients listed
Price context US page from $24; pack options differ $44 / 60 capsules when checked Sale $28.49 / 90 capsules when checked
Quality assessment Manufacturer testing statements; request current-lot CoA Manufacturer quality process; check current certification Manufacturer quality process; distinguish historical market assays
Our preference First choice for a straightforward HCl capsule Alternative for a dual-form preference Conventional alternative

Clinical pharmacology

The product supplies 500 mg per capsule. Its current FAQ describes 500–1,000 mg/day as typical and advises taking it with food and water; consult the current bottle and individualized clinical advice. Several conventional research regimens used 1,000–1,500 mg/day in divided doses, but research exposure is not a universal prescription.

The 116-person metabolic study used 1 g/day, while the early pilot used 1.5 g/day. BRAVO used 1 g/day for six months and did not significantly improve its primary fat outcomes. More is therefore not an established answer to a lack of response.

There is no universal maximum safe intake or cycling schedule established for every formulation and population. Enhanced-delivery mass cannot be converted into an effective conventional dose with a marketing multiplier. Agree on an outcome and reassessment point rather than increasing intake until symptoms appear.

Dose tiers

TierDoseFrequencyDurationNotes
Current manufacturer FAQ 500–1,000 mg/day described as typical Product-specific directions Product instructions; check the current label

The product supplies 500 mg per capsule. The FAQ advises taking it with a meal and water. Subscription quantities for higher intakes describe supply options; they are not a clinical endorsement. The appropriate amount depends on the person, medicines and goal.
Conventional metabolic research Often 1,000–1,500 mg/day in divided doses Divided daily doses in several trials Commonly weeks to months; study-specific

The 116-person trial used 1 g/day, while the early pilot used 1.5 g/day. These describe research exposures, not instructions to increase intake. BRAVO found no significant primary fat-outcome benefit at 1 g/day over six months.
Enhanced formulations Formulation-specific active amounts Do not infer a conversion Acute or longer studies, depending on the preparation

Phytosome complex weight and dihydroberberine amounts should not be converted with a universal multiplier. Higher exposure is not a validated equivalent dose for a clinical outcome. This product is a conventional HCl capsule.

From bench to bedside

PathwayPreclinical findingHuman translationConfidence
AMPK and mitochondrial signaling Experimental energy-state changes can alter AMPK-related pathways. A pathway signal does not establish exercise-equivalent benefits, predictable fat loss or longer human life. Mechanistic evidence; human outcomes assessed separately
Gut microbial metabolism Berberine can affect microbial and metabolite pathways. PREMOTE supports a specific diabetes finding after antibiotic pretreatment, not a universal microbiome upgrade. Human mechanistic signal in a defined protocol
LDL receptor and lipid metabolism Preclinical work suggests changes in lipid handling. Human lipid markers have improved in selected trials; event reduction and product-specific efficacy remain separate questions. Human marker evidence with clinical-outcome limits

Drug interactions

High: demonstrated cyclosporine interaction

Cyclosporine and transplant treatment

Human studies found increased cyclosporine exposure.

Recommendation:

Do not self-add or self-stop berberine around a transplant regimen. Specialist review and appropriate drug monitoring are necessary; a spacing rule is not sufficient.

Medicine-specific caution

Insulin and glucose-lowering regimens

Potential additive glucose effects depend on the full regimen.

Recommendation:

Discuss monitoring, food intake and all medicines with the clinical team. Insulin and insulin secretagogues differ from metformin in hypoglycemia risk; do not replace necessary treatment.

Medicine-specific interaction review

Selected CYP-metabolized medicines

Repeated berberine exposure inhibited measured CYP2D6, CYP2C9 and CYP3A4 activity.

Recommendation:

Have a pharmacist evaluate the exact drug, dose and other clearance pathways. The human probe result does not prove every substrate is affected equally, and two-hour separation cannot guarantee safety.

Caution in susceptible people

Cardiac-rhythm susceptibility

Rare case reports describe prolonged-QT-associated rhythm events in the setting of berberine.

Recommendation:

Discuss known long-QT syndrome, unexplained fainting and rhythm-related medicines before use. Case reports are safety signals, not a population incidence estimate. Fainting or sustained palpitations require urgent assessment.

Bioavailability tips

Follow the exact product directions and the clinician-agreed schedule. Meal association can help routine and tolerability, but a particular clock time is not proven to maximize weight loss. Do not add absorption enhancers or change formulation without considering the resulting exposure and medicines.

Two-hour separation does not reliably eliminate enzyme-mediated interactions. If the regimen is unclear, ask a pharmacist rather than constructing a timing workaround.

Special populations

PopulationRecommendationRationale
Pregnancy and breastfeeding Avoid self-directed use

Safety evidence is inadequate and bilirubin-related infant concerns exist. A pretreatment fertility trial does not establish pregnancy safety. For inadvertent exposure, obtain individualized advice with the product and dates rather than assuming harm.
Children No unsupervised adult-supplement regimen

Adult metabolic trials do not define a safe pediatric amount. Keep capsules and especially sweet dosage forms away from children.
Multiple prescriptions or organ disease Obtain an individualized medication and health review

Selected trial populations may exclude the circumstances that matter most to an individual. Product quality does not remove interaction or tolerability questions.
Healthy adults with normal markers Define the goal before buying

Diabetes and dyslipidemia findings do not automatically establish benefit in a normal-marker population. A clear, measurable objective makes cost and tolerability easier to assess.

Therapeutic positioning

Our preference is for the straightforward conventional-capsule brief: identifiable HCl, 500 mg units, a simple formula and a route to manufacturer documentation. Other conventional products and studied delivery systems can be reasonable alternatives. The comparison concerns label, evidence fit and purchasing value rather than an invented head-to-head clinical result.

Thorne Berberine

Dual-form HCl plus Phytosome Alternative for a specific enhanced-delivery preference

The current two-capsule serving lists 450 mg HCl plus 550 mg Phytosome. The complex mass is not all isolated berberine. It is a reasonable alternative for a reader specifically seeking the dual-form design, but does not establish universal outcome superiority.

NOW Berberine HCl and Integrative Therapeutics Berberine

Other conventional HCl capsules Credible conventional alternatives; DoNotAge remains our preferred simple proposition

Both offer clearly specified conventional options. Compare the exact product, pack, excipients, quality documentation and delivered price. Do not mix facts from NOW’s separate softgel or Phytosome products or from Integrative Therapeutics Berberine Complex.

Dihydroberberine and other delivery systems

Related compound or enhanced formulation Consider exact evidence rather than assuming every enhanced option is better

The five-man DHB pilot showed higher exposure without a significant acute glycemic difference. Phospholipid and micellar products also need exact-formulation evidence. A larger absorption multiplier is not a clinical benefit multiplier.

A supplement should fit within an appropriate clinical and lifestyle plan, not replace nutrition, activity, sleep or necessary medicine. A measurable glucose or lipid objective is easier to evaluate than a vague promise to optimize every aging pathway.

Berberine is not an interchangeable substitute for prescribed diabetes, lipid, blood-pressure or fertility treatment. Do not stop necessary medicines or use this product as a pregnancy, breastfeeding or self-directed infection regimen.

Reader-exclusive

DoNotAge Berberine Review: 500 mg Capsules, Evidence and Value — via DoNotAge

Use code 10% off
  • 60- and 366-capsule options; duration depends on the agreed daily amount
  • Compare the actual subscription quantity, annual-dispatch terms, cancellation rules and checkout total; a supply option is not a dosing recommendation.
  • Fast shipping from DoNotAge
Get 10% off on DoNotAge with BB10 →

DoNotAge handles pricing, fulfilment, and customer support for this product. Biohack Blueprint may earn a commission from purchases made through links on this page, at no extra cost to you. This does not affect our evidence grading or editorial verdict.

About buying through us

Why choose ordinary HCl rather than the biggest absorption claim?

Conventional HCl has relevant human trials and a simple label. Enhanced exposure can be useful, but the exact formulation still needs clinical outcome evidence; the highest multiplier does not automatically identify the best product.

Why recommend it when weight-loss findings are mixed?

Our preference concerns a clear conventional product proposition for an appropriate metabolic goal. It does not depend on a guaranteed weight-loss claim, and the review keeps the null findings visible.

Does the affiliate relationship affect the recommendation?

Biohack Blueprint earns commission from qualifying DoNotAge purchases and discloses that relationship. The product preference is an editorial assessment; clinical claims remain tied to the actual studies and their limitations.

What does the 5/5 rating mean?

It is a subjective product-fit recommendation for the stated conventional-capsule criteria. It is not an independent lab result, a clinical-efficacy grade or proof that the product has outperformed all competitors in a trial.

Should I choose a 366-capsule pack immediately?

Compare the actual checkout terms and whether the product and intended routine are suitable first. A large pack’s supply arithmetic is not a recommendation for a particular dose or duration.

Reader questions

Is DoNotAge Berberine our recommended option?

Yes, for a reader seeking a straightforward conventional 500 mg HCl capsule after an appropriate safety review. The recommendation is a disclosed editorial preference, not proof of superior disease-treatment efficacy.

How much berberine is in each capsule?

The official product page states 500 mg per capsule. Capsule amount is not the same as the right daily intake for every person; follow the label and individualized advice.

Is the purity 98% or 99.8%?

The current berberine product quality section states 98%. A higher figure used for another ingredient should not be transferred to this product; request the current lot’s certificate for assay details.

Did Biohack Blueprint test the capsules in a laboratory?

No. This review evaluates published research, current manufacturer information and product fit. It does not claim an independent laboratory assay of the retail lot.

Was DoNotAge tested in the cited clinical trials?

The cited findings do not establish that the current DoNotAge retail bottle was the trial intervention. The product assessment and the ingredient evidence are described separately.

Can BB10 be used when buying?

Use BB10 for 10% off eligible purchases and confirm the final checkout price and exclusions. Our tracked link is an affiliate referral, and the order is placed with DoNotAge.

Does the product guarantee weight loss?

No. General berberine weight effects are modest and inconsistent, and the large BRAVO trial did not improve its primary fat outcomes. A good capsule does not remove that evidence limitation.

Can it be taken with medicines?

Have a pharmacist or prescriber assess the complete regimen. Berberine has demonstrated interaction potential, particularly with cyclosporine and through effects on drug-metabolizing enzymes.

Editorial credibility

Portrait of Dr. Khaled Mahmoud, ICU physician and founder of Biohack Blueprint

Author

Dr. Khaled Mahmoud, MBBCh

MBBCh

Critical Care Medicine, Longevity Science & Editorial Direction

Portrait of Dr. Amr Yasser, cardiometabolic and musculoskeletal reviewer for Biohack Blueprint

Reviewer

Dr. Amr Yasser, PhD

MBBCh, PhD, General Surgery, Cardiometabolic Medicine, Musculoskeletal Research

Cardiometabolic, Musculoskeletal, Gut & Bioavailability

Portrait of Dr. Abdulla Mostafa, neuroscience reviewer for Biohack Blueprint

Reviewer

Dr. Abdulla Mostafa, PhD

MBBCh, PhD, Neuroscience, Neurosurgery

Cellular Senescence, Neurological, Mitochondrial & Brain-Ageing Biology

Subjective product-fit score for a clear conventional formula, practical capsule amount, simple ingredients, manufacturer documentation route and value. Not a clinical-efficacy or independent laboratory score.

Ready to try DoNotAge Berberine Review: 500 mg Capsules, Evidence and Value?

Use code BB10 for 10% off on DoNotAge.

Shop DoNotAge Berberine Review: 500 mg Capsules, Evidence and Value on DoNotAge →

Partner link. Biohack Blueprint may earn a commission at no extra cost to you.

Related reading

Berberine Benefits: What Human Studies Actually Show

Berberine for Weight Loss: Results, Before and After Claims and Evidence

Berberine Dosage: Study Doses, Capsule Strengths and Safety

Best Time to Take Berberine: Meals, Morning or Night?

Berberine Side Effects: Digestive Symptoms and Long-Term Safety

Berberine Interactions: Medicines, Supplements and Alcohol

Berberine During Pregnancy and Breastfeeding: Safety Explained

Berberine for Blood Sugar: Diabetes, Insulin Resistance and HbA1c

Berberine for Cholesterol: LDL, ApoB and Triglyceride Evidence

Berberine and Fatty Liver: What MASLD Trials Show

Berberine and Blood Pressure: Evidence and Medication Questions

Berberine for PCOS: Metabolic and Fertility Evidence Reassessed

Berberine vs Metformin: Differences and Taking Them Together

Berberine vs Ozempic: Is It Really Nature’s Ozempic?

Berberine vs Inositol: PCOS, Insulin Resistance and Combinations

Berberine for Menopause Weight Gain: What Evidence Applies?

Berberine for SIBO: Trial Evidence, Herbal Formulas and Safety

Berberine and Gut Health: Microbiome, IBS and Infection Research

Berberine HCl: Hydrochloride, Plant Extracts and Label Differences

Dihydroberberine vs Berberine: Absorption, Benefits and Evidence

Berberine Phytosome vs Liposomal Berberine: Absorption Explained

Berberine Patches: Do They Work for Weight Loss?

Berberine Gummies vs Capsules: Dose, Ingredients and Evidence

Berberine and Cinnamon: Combination Benefits and Study Limits

Berberine and Milk Thistle: Silymarin Combination Evidence

Berberine Food Sources: Barberry, Goldenseal and Plant Extracts

Berberine, AMPK and Longevity: Mechanisms vs Human Outcomes

Best Berberine Supplements: Formulas, Testing and Value Compared
  1. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine Zhang Y, Li X, Zou D, Liu W, Yang J, Zhu N, Huo L, Wang M, Hong J, Wu P, Ren G, Ning G (2008) . The Journal of clinical endocrinology and metabolism Read on our Data CenterView on PubMed DOI
  2. Efficacy of berberine in patients with type 2 diabetes mellitus Yin J, Xing H, Ye J (2008) . Metabolism: clinical and experimental Read on our Data CenterView on PubMed View on PMC DOI
  3. Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study) Zhang Y, Gu Y, Ren H, Wang S, Zhong H, Zhao X, Ma J, Gu X, Xue Y, Huang S, Yang J, Chen L, Chen G, Qu S, Liang J, Qin L, Huang Q, Peng Y, Li Q, Wang X, Kong P, Hou G, Gao M, Shi Z, Li X, Qiu Y, Zou Y, Yang H, Wang J, Xu G, Lai S, Li J, Ning G, Wang W (2020) . Nature communications Read on our Data CenterView on PubMed View on PMC DOI Clinical Trial
  4. Efficacy and safety of HIMABERB® Berberine on glycemic control in patients with prediabetes: double-blind, placebo-controlled, and randomized pilot trial Panigrahi A, Mohanty S (2023) . BMC endocrine disorders Read on our Data CenterView on PubMed View on PMC DOI
  5. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, Wang Y, Wang Z, Si S, Pan H, Wang S, Wu J, Wang Y, Li Z, Liu J, Jiang JD (2004) . Nature medicine Read on our Data CenterView on PubMed DOI
  6. Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials Blais JE, Huang X, Zhao JV (2023) . Drugs Read on our Data CenterView on PubMed DOI
  7. Sex-Specific Lipid, Apolipoprotein B, and Lipoprotein(a) Responses to Berberine Based on 2 Randomized Placebo-Controlled Trials Zhao JV, Chen B, Chan YH, Zhang J, Xia Y, Blais JE, Chen H, Tomlinson B, Ip DKM (2026) . JACC. Asia Read on our Data CenterView on PubMed View on PMC DOI
  8. The effect of berberine on obesity indices: a systematic review and meta-analysis Elahi Vahed I, Shahir-Roudi E, Nojumi S, Golmohammadi S, Moradi Shahrebabak M, Sharafi Tafreshi Moghadam N, Bagheryan AS, Moftakhar M, Shamsipour F, Jafari M, Soltaninejad H, Rahmanian M (2026) . International journal of obesity (2005) Read on our Data CenterView on PubMed DOI
  9. Berberine and Adiposity in Diabetes-Free Individuals With Obesity and MASLD: A Randomized Clinical Trial Lei L, Wang B, Zhao L, Li J, Yan X, Jiang J, Wang L, Ren G, Li Y, Cheng X, Yan X, Zhu Y, Guo Y, Zhong H, Zhang H, Li J, BRAVO Collaborative Group (2026) . JAMA network open Read on our Data CenterView on PubMed View on PMC DOI Clinical Trial
  10. Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease Yan HM, Xia MF, Wang Y, Chang XX, Yao XZ, Rao SX, Zeng MS, Tu YF, Feng R, Jia WP, Liu J, Deng W, Jiang JD, Gao X (2015) . PloS one Read on our Data CenterView on PubMed View on PMC DOI Clinical Trial
  11. Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes: A Randomized Clinical Trial Ji L, Ma J, Ma Y, Cheng Z, Gan S, Yuan G, Liu D, Li S, Liu Y, Xue X, Bai J, Wang K, Cai H, Li S, Liu K, Yu M, Liu L (2025) . JAMA network open Read on our Data CenterView on PubMed View on PMC DOI Clinical Trial
  12. Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action Turner N, Li JY, Gosby A, To SW, Cheng Z, Miyoshi H, Taketo MM, Cooney GJ, Kraegen EW, James DE, Hu LH, Li J, Ye JM (2008) . Diabetes Read on our Data CenterView on PubMed DOI
  13. Berberine ameliorates cellular senescence and extends the lifespan of mice via regulating p16 and cyclin protein expression Dang Y, An Y, He J, Huang B, Zhu J, Gao M, Zhang S, Wang X, Yang B, Xie Z (2020) . Aging cell Read on our Data CenterView on PubMed View on PMC DOI
  14. Berberine Extends Lifespan in C. elegans Through Multi-Target Synergistic Antioxidant Effects Bei Y, Wang T, Guan S (2025) . Antioxidants (Basel, Switzerland) Read on our Data CenterView on PubMed View on PMC DOI
  15. Variability in Potency Among Commercial Preparations of Berberine Funk RS, Singh RK, Winefield RD, Kandel SE, Ruisinger JF, Moriarty PM, Backes JM (2018) . Journal of dietary supplements Read on our Data CenterView on PubMed View on PMC DOI
  16. Repeated administration of berberine inhibits cytochromes P450 in humans Guo Y, Chen Y, Tan ZR, Klaassen CD, Zhou HH (2012) . European journal of clinical pharmacology Read on our Data CenterView on PubMed View on PMC DOI
  17. Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study Wu X, Li Q, Xin H, Yu A, Zhong M (2005) . European journal of clinical pharmacology Read on our Data CenterView on PubMed DOI
  18. Displacement of bilirubin from albumin by berberine Chan E (1993) . Biology of the neonate Read on our Data CenterView on PubMed DOI
  19. Natural Is Not Always Safe: A Case of Torsades De Pointes Induced by Berberine Supplementation Williams JM, Yadlapalli N, Franchi F (2026) . Cureus Read on our Data CenterView on PubMed View on PMC DOI
  20. Correction: Natural Is Not Always Safe: A Case of Torsades De Pointes Induced by Berberine Supplementation Williams JM, Yadlapalli N, Franchi F (2026) . Cureus Read on our Data CenterView on PubMed View on PMC DOI
  21. Questionable Evidence for Berberine in Polyendocrine Metabolic Ovarian Syndrome: An Integrity-Based Reappraisal Perera E, Mantzioris E, Moran L, Scannell N, Villani A, Rao V, Mousa A, Flannagan M, Ee C (2026) . Advances in therapy Read on our Data CenterView on PubMed DOI
  22. Randomized controlled trial of letrozole, berberine, or a combination for infertility in the polycystic ovary syndrome Wu XK, Wang YY, Liu JP, Liang RN, Xue HY, Ma HX, Shao XG, Ng EH, Reproductive and Developmental Network in Chinese Medicine (2016) . Fertility and sterility Read on our Data CenterView on PubMed DOI
  23. Development of an Innovative Berberine Food-Grade Formulation with an Ameliorated Absorption: In Vitro Evidence Confirmed by Healthy Human Volunteers Pharmacokinetic Study Petrangolini G, Corti F, Ronchi M, Arnoldi L, Allegrini P, Riva A (2021) . Evidence-based complementary and alternative medicine : eCAM Read on our Data CenterView on PubMed View on PMC DOI
  24. Absorption Kinetics of Berberine and Dihydroberberine and Their Impact on Glycemia: A Randomized, Controlled, Crossover Pilot Trial Moon JM, Ratliff KM, Hagele AM, Stecker RA, Mumford PW, Kerksick CM (2021) . Nutrients Read on our Data CenterView on PubMed View on PMC DOI
  • 22 Oct 2026 Published with current study results, formulation distinctions, safety information and linked original sources.
First published 22 Oct 2026 · Last verified 22 Oct 2026